Skip to content

Breaking up prolonged sitting with intermittent standing: acute effects in overweight inactive adults.

The acute effect of breaking up prolonged sitting with intermittent bouts of short-duration standing on postprandial glucose metabolism, lipid metabolism and vascular function in overweight/obese adults.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000664842
Acronym
The STOMP (Standing To Offset the Metabolic derangement of Prolonged sitting) study
Enrollment
10
Registered
2012-06-21
Start date
2012-06-29
Completion date
2012-07-27
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

It is well known that being physically active is important for maintaining good health. However, new evidence has emerged showing that being sedentary (sitting for prolonged periods) is adversely associated with indicators of poor health, such as elevated blood glucose and blood fats. Recent experimental evidence suggests that breaking up sitting time throughout the day with light-intensity activity (ie. walking) results in lower blood glucose and blood fat levels than sitting for prolonged periods without activity breaks. However, it is not known whether short-duration bouts of standing, of comparable frequency, can elicit similar metabolic benefits to those observed with treadmill walking. Consequently, this study aims to test the acute (7-hour) effect of prolonged sitting on glucose metabolism and vascular function with and without intermittent breaks of standing.

Interventions

The experimental condition involves a single day of prolonged sitting (total duration= 7hrs) with intermittent bouts of short-duration standing. Participants will remain seated for the initial 140min (steady state) period, after which they will consume a standardised mixed meal (50g fat, 75g carbohydrate) and will complete a 2min bout of standing every 20mins for the remaining 5 hours (total standing duration:28mins). All activities will take place in a controlled laboratory environment under t

The experimental condition involves a single day of prolonged sitting (total duration= 7hrs) with intermittent bouts of short-duration standing. Participants will remain seated for the initial 140min (steady state) period, after which they will consume a standardised mixed meal (50g fat, 75g carbohydrate) and will complete a 2min bout of standing every 20mins for the remaining 5 hours (total standing duration:28mins). All activities will take place in a controlled laboratory environment under the supervision of trained clinical research staff. During the condition, participants will be permitted to watch television, DVD’s or read. In this trial, participants will complete each condition (experimental and control) in random order, with a minimum 7 day washout period between conditions.

Sponsors

Baker IDI Heart and Diabetes Institute
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Inclusion criteria includes: overweight or obesity (body mass index greater than or equal to 25kg/m2 but less than or equal to 45kg/m2) and English speaking

Exclusion criteria

Exclusion is based on: of pregnancy; employment in a non-sedentary occupation (< 5 hours total sitting during the typical workday); currently watching < 3 hours of total screen (including television, computer or electronic games) time per day; regularly engaged in moderate-vigorous physical activity greater than or equal to 150min/week > 3 months; use of carbohydrate or lipid-lowering medication; greater than or equal to 5 previous vasovagal syncope episodes or epilepsy; known physical activity contraindications; major illness/injury (acute or chronic), smokers; orthostatic intolerance, and the use of aspirin or other anticoagulants.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026